The Procter & Gamble Company (NYSE:PG) Position Decreased by Smithbridge Asset Management Inc. DE

Smithbridge Asset Management Inc. DE reduced its stake in shares of The Procter & Gamble Company (NYSE:PGFree Report) by 1.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 35,553 shares of the company’s stock after selling 435 shares during the quarter. Procter & Gamble makes up approximately 1.2% of Smithbridge Asset Management Inc. DE’s portfolio, making the stock its 28th largest position. Smithbridge Asset Management Inc. DE’s holdings in Procter & Gamble were worth $5,210,000 as of its most recent SEC filing.

Other institutional investors have also made changes to their positions in the company. Proquility Private Wealth Partners LLC grew its holdings in shares of Procter & Gamble by 1.1% during the 2nd quarter. Proquility Private Wealth Partners LLC now owns 6,008 shares of the company’s stock worth $912,000 after purchasing an additional 66 shares in the last quarter. KFA Private Wealth Group LLC grew its holdings in shares of Procter & Gamble by 2.2% during the 3rd quarter. KFA Private Wealth Group LLC now owns 3,054 shares of the company’s stock worth $445,000 after purchasing an additional 67 shares in the last quarter. Chemistry Wealth Management LLC grew its holdings in shares of Procter & Gamble by 1.2% during the 4th quarter. Chemistry Wealth Management LLC now owns 5,839 shares of the company’s stock worth $856,000 after purchasing an additional 67 shares in the last quarter. Watchman Group Inc. grew its holdings in shares of Procter & Gamble by 0.4% during the 3rd quarter. Watchman Group Inc. now owns 18,052 shares of the company’s stock worth $2,633,000 after purchasing an additional 68 shares in the last quarter. Finally, Auxier Asset Management boosted its stake in Procter & Gamble by 0.3% in the third quarter. Auxier Asset Management now owns 20,448 shares of the company’s stock valued at $2,983,000 after buying an additional 68 shares in the last quarter. 65.77% of the stock is currently owned by institutional investors and hedge funds.

Procter & Gamble Stock Down 0.3 %

Shares of NYSE:PG traded down $0.47 during mid-day trading on Thursday, hitting $162.14. 3,075,663 shares of the company traded hands, compared to its average volume of 6,839,737. The stock has a market cap of $381.52 billion, a P/E ratio of 27.18, a P/E/G ratio of 3.28 and a beta of 0.44. The company has a current ratio of 0.64, a quick ratio of 0.44 and a debt-to-equity ratio of 0.48. The Procter & Gamble Company has a 12-month low of $141.45 and a 12-month high of $163.14. The stock has a 50-day moving average price of $158.17 and a two-hundred day moving average price of $152.09.

Procter & Gamble (NYSE:PGGet Free Report) last posted its quarterly earnings data on Tuesday, January 23rd. The company reported $1.84 earnings per share for the quarter, topping the consensus estimate of $1.70 by $0.14. The business had revenue of $21.44 billion for the quarter, compared to analysts’ expectations of $21.48 billion. Procter & Gamble had a return on equity of 34.04% and a net margin of 17.60%. The business’s revenue was up 3.2% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.59 earnings per share. On average, equities research analysts forecast that The Procter & Gamble Company will post 6.45 earnings per share for the current year.

Procter & Gamble Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, February 15th. Investors of record on Friday, January 19th were given a $0.9407 dividend. The ex-dividend date was Thursday, January 18th. This represents a $3.76 dividend on an annualized basis and a yield of 2.32%. Procter & Gamble’s dividend payout ratio is presently 62.98%.

Insider Buying and Selling

In other Procter & Gamble news, CEO Gary A. Coombe sold 22,000 shares of the stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $161.32, for a total value of $3,549,040.00. Following the sale, the chief executive officer now owns 36,845 shares in the company, valued at $5,943,835.40. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. In other news, CEO Gary A. Coombe sold 22,000 shares of the firm’s stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $161.32, for a total transaction of $3,549,040.00. Following the transaction, the chief executive officer now owns 36,845 shares in the company, valued at $5,943,835.40. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO R. Alexandra Keith sold 776 shares of the firm’s stock in a transaction on Monday, March 4th. The shares were sold at an average price of $158.11, for a total value of $122,693.36. Following the transaction, the chief executive officer now owns 4,859 shares in the company, valued at approximately $768,256.49. The disclosure for this sale can be found here. Insiders sold a total of 279,063 shares of company stock worth $43,187,745 over the last three months. 0.17% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

Several research firms recently weighed in on PG. Stifel Nicolaus raised their price objective on Procter & Gamble from $155.00 to $157.00 and gave the company a “hold” rating in a research note on Wednesday, January 24th. Wells Fargo & Company lifted their price target on Procter & Gamble from $162.00 to $170.00 and gave the company an “overweight” rating in a research note on Wednesday, January 24th. JPMorgan Chase & Co. cut their price target on Procter & Gamble from $169.00 to $162.00 and set an “overweight” rating on the stock in a research note on Thursday, January 18th. Royal Bank of Canada raised their price objective on Procter & Gamble from $156.00 to $157.00 and gave the stock a “sector perform” rating in a research report on Wednesday, January 24th. Finally, Raymond James raised their price objective on Procter & Gamble from $170.00 to $175.00 and gave the stock an “outperform” rating in a research report on Wednesday, January 24th. Seven analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. According to MarketBeat, Procter & Gamble currently has an average rating of “Moderate Buy” and a consensus target price of $168.41.

Get Our Latest Stock Analysis on PG

Procter & Gamble Company Profile

(Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

Read More

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.